Form 4: Director Mark Fleischhauer Sells Anterix Shares
Statement of Changes in Beneficial Ownership
Anterix Inc. Director Mark Fleischhauer sold 3,500 shares of common stock at an average price of $79.8294.
Summary
- Director Mark Fleischhauer executed a sale of 3,500 shares of Anterix Inc. (ATEX) common stock.
- The transaction occurred on June 15, 2026.
- The shares were sold at a price of $79.8294 per share.
- Following this transaction, the director retains beneficial ownership of 12,769 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as routine insider selling is a standard practice and does not inherently signal negative corporate performance.
Positives
- The director maintains a remaining stake of 12,769 shares, indicating continued alignment with the company's long-term performance.
Negatives
- Insider selling can sometimes be perceived by the market as a lack of confidence in near-term stock appreciation.
Risks
- Market volatility affecting the share price of Anterix Inc.
Future Outlook
No specific forward-looking guidance was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that insider sales are common occurrences for portfolio rebalancing or liquidity needs and do not necessarily reflect a change in the company's fundamental business outlook.
Comparison to Industry Standards
- Insider transactions are standard regulatory disclosures for publicly traded companies in the United States.
- The volume of shares sold represents a small fraction of the director's total holdings, which is consistent with typical executive equity management.
Stakeholder Impact
- Minimal impact expected on shareholders as the sale represents a routine disclosure of insider activity.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 06/15/2026 | Date of the stock sale transaction. |
| 06/16/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Anterix, ATEX, Insider Trading, Form 4, Director Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.